Trial intelligence / Profile preview

Warming Sensation and Acceptability of Paracetamol, Phenylephrine, and Guaifenesin Syrup in URTI

NCT01576809Phase 3Completed

Sponsor
Novartis
Start
Mar 2012
Primary completion
May 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of acetaminophen, phenylephrine, guaifenesin in upper respiratory tract infection (URI), sponsored by Novartis. Started Mar 2012; status: completed.

02

Drugs

acetaminophenphenylephrineguaifenesin
03

Conditions

upper respiratory tract infection (URI)

Beyond the preview

Go deeper on NCT01576809.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01576809.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call